Details for Patent: 8,808,737
✉ Email this page to a colleague
Which drugs does patent 8,808,737 protect, and when does it expire?
Patent 8,808,737 protects OPANA ER and is included in two NDAs.
Summary for Patent: 8,808,737
| Title: | Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment |
| Abstract: | The invention pertains to a method of using oxymorphone in the treatment of pain by providing a patient with an oxymorphone dosage form and informing the patient or prescribing physician that the bioavailability of oxymorphone is increased in patients with renal impairment. |
| Inventor(s): | Ahdieh; Harry (Lincoln University, PA) |
| Assignee: | Endo Pharmaceuticals Inc. (Malvern, PA) |
| Application Number: | 12/716,973 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,808,737 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 8,808,737
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-001 | Jun 22, 2006 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | DOSE MODIFICATION FOR RENAL IMPAIRMENT | ⤷ Sign Up | ||||
| Endo Operations | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-005 | Feb 29, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | DOSE MODIFICATION FOR RENAL IMPAIRMENT | ⤷ Sign Up | ||||
| Endo Operations | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-002 | Jun 22, 2006 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | DOSE MODIFICATION FOR RENAL IMPAIRMENT | ⤷ Sign Up | ||||
| Endo Operations | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-006 | Feb 29, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | DOSE MODIFICATION FOR RENAL IMPAIRMENT | ⤷ Sign Up | ||||
| Endo Operations | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-003 | Jun 22, 2006 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | DOSE MODIFICATION FOR RENAL IMPAIRMENT | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
